Discover 2,591 paid clinical trials in Illinois. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Illinois offers various clinical research options, including those for healthy volunteers interested in paid studies, as well as for individuals with specific health conditions. Leading research centers in Chicago, Plainfield, and Springfield are actively seeking participants, providing access to innovative treatments and personalized care.
Filter
1
Filter results
Results: 2,591
IVIG in the Treatment of Autoimmune Small Fiber Neuropathy With TS-HDS, FGFR-3, or Plexin D1 Antibodies
for
Small Fiber Neuropathy, Autoimmune Small Fiber Neuropathy,
Location: Glenview IL
Sponsor: Endeavor Health
Sex: All
Age: 18+
Code: NCT04153422
Phase 2, Recruiting
FFP In Traumatic BRAin INjury (FIT-BRAIN) Trial
for
Moderate to Severe Traumatic Brain Injury
Location: Chicago IL
Sponsor: Northwestern University
Sex: All
Age: 18 - 65
Code: NCT06062888
Phase 2, Phase 3, Recruiting
Ultra-High Frequency - Electrocardiogram (UHF-ECG) for the Diagnosis of Ventricular Electrical Dyssynchrony (VED)
Location: Charlottesville VA, Columbus OH, Chicago IL,
Sponsor: VDI Technologies
Sex: All
Age: 18+
Code: NCT06641362
Recruiting
Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.
Get alerts for new trials in your area by subscribing now
The INFLUENTIAL Trial- Evaluation of National Inpatient Influenza Vaccination Program
for
Influenza
Location: Chicago IL, Seattle WA
Sponsor: University of Colorado, Denver
Sex: All
Age: 0 - 70+
Code: NCT05832307
Recruiting
Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
for
Small Cell Lung Cancer, Small Cell Lung Cancer ( SCLC ),
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07476287
Phase 2, Recruiting
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
Medical Management With Endovascular Thrombectomy Versus Medical Management Alone in Patients Presenting Beyond 24 Hours of Last Known Well
for
Acute Ischemic Stroke
Location: Providence RI, Morgantown WV, Chicago IL, St Louis MO,
Sponsor: Amrou Sarraj
Sex: All
Age: 18 - 70+
Code: NCT07115940
Recruiting
Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)
Sponsor: Stichting Hemato-Oncologie voor Volwassenen Nederland
Sex: All
Age: 18+
Code: NCT07223814
Phase 3, Recruiting
The SENTINL-1 Study: Evaluating Patient-Reported Outcomes of AI-Inferred Lung Cancer Risk
for
Lung Cancer
Location: Chicago IL
Sponsor: University of Illinois at Chicago
Sex: All
Age: 50 - 70+
Code: NCT07458425
Recruiting
Noninvasive Vagal Nerve Stimulation and Cognitive Rehabilitation
for
Traumatic Brain Injury
Location: Chicago IL
Sponsor: Shirley Ryan AbilityLab
Sex: All
Age: 18 - 65
Code: NCT06589362
Recruiting
Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer
for
Non Small Cell Lung Cancer
Location: Milford DE, Dover DE, Elk Grove Village IL, Houston TX,
Sponsor: N-Power Medicine
Sex: All
Age: 18+
Code: NCT07028489
Recruiting
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
for
Breast Neoplasms
Location: Boston MA, Sherbrooke, Westbury NY, White Plains NY,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT06926868
Phase 2, Phase 3, Recruiting
Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease
for
Refractory Metastatic Colorectal Cancer
Location: Chapel Hill NC, Miami FL, Tampa FL, Chicago IL,
Sponsor: Delcath Systems Inc.
Sex: All
Age: 18+
Code: NCT06607458
Phase 2, Recruiting
Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
for
Chronic Inflammatory Demyelinating Polyneuropathy
Location: Boston MA, Worcester MA, New Haven CT, New York NY,
Sponsor: Immunovant Sciences GmbH
Sex: All
Age: 18+
Code: NCT07032662
Phase 2, Recruiting
Comparing Single-Session Therapies for Chronic Pain
Location: Roslyn NY, The Bronx NY, Norfolk VA, Charleston SC,
Sponsor: Abbott Medical Devices
Sex: All
Age: 18+
Code: NCT07069673
Recruiting
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
for
Prostate Cancer
Location: Boston MA, Hartford CT, The Bronx NY, New York NY,
Sponsor: Novartis Pharmaceuticals
Sex: Male
Age: 18 - 70+
Code: NCT06780670
Phase 2, Phase 3, Recruiting
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
for
Metastatic Solid Tumor, Recurrent Solid Tumor,
Location: Boston MA, New York NY, Cleveland OH, Atlanta GA,